Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a-Reference-Cited by-同舟云学术

Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a

Published:2018-04-18 Issue:1 Volume:11 Page:
ISSN:1756-8722
Container-title:Journal of Hematology & Oncology
language:en
Short-container-title:J Hematol Oncol

Author:

Cao Man-Qing,You A-Bin,Zhu Xiao-Dong,Zhang Wei,Zhang Yuan-Yuan,Zhang Shi-Zhe,Zhang Kei-wei,Cai Hao,Shi Wen-Kai,Li Xiao-Long,Li Kang-Shuai,Gao Dong-Mei,Ma De-Ning,Ye Bo-Gen,Wang Cheng-Hao,Qin Cheng-Dong,Sun Hui-Chan,Zhang Ti,Tang Zhao-You

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Biology,Hematology

Link

http://link.springer.com/content/pdf/10.1186/s13045-018-0599-z.pdf

Reference1 articles.

1. Cao M-Q, et al. miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a. J Hematol Oncol. 2018;11:12.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene Coexpression and miRNA Regulation: A Path to Early Intervention in Colorectal Cancer;Human Gene Therapy;2024-07-04

2. Deciphering the cross-talk between miRNA and tight junctions in hepatocellular carcinoma;Exploration of Digestive Diseases;2024-05-11

3. Progress in the study of FOXO3a interacting with microRNA to regulate tumourigenesis development;Frontiers in Oncology;2023-10-27

4. Baicalin Reduces Renal Inflammation in Mesangial Proliferative Glomerulonephritis through Activation of Nrf2/ARE and PI3K/AKT Pathways;Discovery Medicine;2023

5. Tetramethylpyrazine: A review of the most recent research;Pharmacological Research - Modern Chinese Medicine;2022-12